食欲相关因子在精神分裂症睡眠障碍中的研究进展(4)
[18]an der Heiden W，Konnecke R，Maurer K，et al.Depression in the longterm course of schizophrenia[J].Eur Arch Psychiatry Clin Neurosci，2005，255(3)：174184.
[19]Lutter M，Sakata I，OsborneLawrence S，et al.The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress[J].Nat Neurosci，2008，11(7)：752753.
[20]Tolle V，Bassant MH，Zizzari P，et al.Ultradian rhythmicity of ghrelin secretion in relation with GH，feeding behavior，and sleepwake patterns in rats[J].Endocrinology，2002，143(4)：13531361.
, 百拇医药
[21]Heilig M.The NPY system in stress，anxiety and depression[J].Neuropeptides，2004，38(4)：213224.
[22]Karl T，Herzog H.Behavioral profiling of NPY in aggression and neuropsychiatric diseases[J].Peptides，2007，28(2)：326333.
[23]Barnea A，Roberts J.Induction of functional and morphological expression of neuropeptide Y (NPY) in cortical cultures by brainderived neurotrophic factor (BDNF)：evidence for a requirement for extracellularregulated kinase (ERK)dependent and ERKindependent mechanisms[J].Brain Res，2001，919(1)：5769.
, 百拇医药
[24]Itokawa M，Arai M，Kato S，et al.Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans[J].Neurosci Lett，2003，347(3)：202204.
[25]He C，Yang Y，Zhang M，et al.Regulation of sleep by neuropeptide Ylike system in Drosophila melanogaster[J].PLoS One，2013，8(9)：74237.
[26]Steiger A.Neurochemical regulation of sleep[J].J Psychiatr Res，2007，41(7)：537552.
, 百拇医药
[27]de Lecea L，Huerta R.Hypocretin (orexin) regulation of sleeptowake transitions[J].Front Pharmacol，2014，5：16.
[28]Antonijevic IA，Murck H，Bohlhalter S，et al.Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men[J].Neuropharmacology，2000，39(8)：14741481.
[29]Dyzma M，Boudjeltia KZ，Faraut B，et al.Neuropeptide Y and sleep[J].Sleep Med Rev，2010，14(3)：161165.
[30]Fadel JR，Jolivalt CG，Reagan LP.Food for thought：the role of appetitive peptides in agerelated cognitive decline[J].Ageing Res Rev，2013，12(3)：764776.
, 百拇医药
[31]Yoon JH，Minzenberg MJ，Raouf S，et al.Impaired prefrontalbasal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia[J].Biol Psychiatry，2013，74(2)：122129.
[32]Dalal MA，Schuld A，Pollmacher T.Lower CSF orexin A (hypocretin1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects[J].Mol Psychiatry，2003，8(10)：836837.
[33]Scammell TE，Arrigoni E，Lipton JO.Neural Circuitry of Wakefulness and Sleep[J].Neuron，2017，93(4)：747765., 百拇医药(武琪 李慧 王帆)
[19]Lutter M，Sakata I，OsborneLawrence S，et al.The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress[J].Nat Neurosci，2008，11(7)：752753.
[20]Tolle V，Bassant MH，Zizzari P，et al.Ultradian rhythmicity of ghrelin secretion in relation with GH，feeding behavior，and sleepwake patterns in rats[J].Endocrinology，2002，143(4)：13531361.
, 百拇医药
[21]Heilig M.The NPY system in stress，anxiety and depression[J].Neuropeptides，2004，38(4)：213224.
[22]Karl T，Herzog H.Behavioral profiling of NPY in aggression and neuropsychiatric diseases[J].Peptides，2007，28(2)：326333.
[23]Barnea A，Roberts J.Induction of functional and morphological expression of neuropeptide Y (NPY) in cortical cultures by brainderived neurotrophic factor (BDNF)：evidence for a requirement for extracellularregulated kinase (ERK)dependent and ERKindependent mechanisms[J].Brain Res，2001，919(1)：5769.
, 百拇医药
[24]Itokawa M，Arai M，Kato S，et al.Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans[J].Neurosci Lett，2003，347(3)：202204.
[25]He C，Yang Y，Zhang M，et al.Regulation of sleep by neuropeptide Ylike system in Drosophila melanogaster[J].PLoS One，2013，8(9)：74237.
[26]Steiger A.Neurochemical regulation of sleep[J].J Psychiatr Res，2007，41(7)：537552.
, 百拇医药
[27]de Lecea L，Huerta R.Hypocretin (orexin) regulation of sleeptowake transitions[J].Front Pharmacol，2014，5：16.
[28]Antonijevic IA，Murck H，Bohlhalter S，et al.Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men[J].Neuropharmacology，2000，39(8)：14741481.
[29]Dyzma M，Boudjeltia KZ，Faraut B，et al.Neuropeptide Y and sleep[J].Sleep Med Rev，2010，14(3)：161165.
[30]Fadel JR，Jolivalt CG，Reagan LP.Food for thought：the role of appetitive peptides in agerelated cognitive decline[J].Ageing Res Rev，2013，12(3)：764776.
, 百拇医药
[31]Yoon JH，Minzenberg MJ，Raouf S，et al.Impaired prefrontalbasal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia[J].Biol Psychiatry，2013，74(2)：122129.
[32]Dalal MA，Schuld A，Pollmacher T.Lower CSF orexin A (hypocretin1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects[J].Mol Psychiatry，2003，8(10)：836837.
[33]Scammell TE，Arrigoni E，Lipton JO.Neural Circuitry of Wakefulness and Sleep[J].Neuron，2017，93(4)：747765., 百拇医药(武琪 李慧 王帆)